Literature DB >> 21578692

cis-Diammine(glycolato-κO,O)platinum(II).

Qing-Kun Wang, Shao-Ping Pu, Yan-Wei Cong, Yong-Nian Li, Chun-Fang Luan.   

Abstract

The reaction of cis-[Pt(NO(3))(2)(NH(3))(2)] and sodium glycolate yielded the title compound, [Pt(C(2)H(2)O(3))(NH(3))(2)]. The Pt(II) atom, coordinated by two N atoms of ammine and two O atoms of the carboxyl-ate and oxido groups of the glycolate ligand, is in a square-planar environment. In the crystal structure, mol-ecules are connected by inter-molecular N-H⋯O hydrogen bonds, forming a three-dimensional network.

Entities:  

Year:  2009        PMID: 21578692      PMCID: PMC2972061          DOI: 10.1107/S1600536809049757

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

The title compound is a second-generation platinum derivative that has an anti­tumour activity comparable to that of cisplatin, one of the most effective anti-cancer drugs for testicular, lung, bladder and other carcinomas, but which is less toxic to the kidney, see: Inuyama et al. (1992 ▶); Kameyama et al. (1990 ▶); Noda et al. (1992 ▶); Taguchi et al. (1992 ▶); Yamamoto et al. (2000 ▶). For related structures, see: Yuge & Miyamoto (1998 ▶); Griffith et al. (2007 ▶).

Experimental

Crystal data

[Pt(C2H2O3)(NH3)2] M = 303.19 Orthorhombic, a = 5.6293 (6) Å b = 7.2853 (8) Å c = 14.1107 (16) Å V = 578.70 (11) Å3 Z = 4 Mo Kα radiation μ = 24.17 mm−1 T = 298 K 0.24 × 0.12 × 0.10 mm

Data collection

Bruker APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 2002 ▶) T min = 0.068, T max = 0.196 3739 measured reflections 1354 independent reflections 1307 reflections with I > 2σ(I) R int = 0.034

Refinement

R[F 2 > 2σ(F 2)] = 0.020 wR(F 2) = 0.042 S = 0.99 1354 reflections 76 parameters H-atom parameters constrained Δρmax = 1.24 e Å−3 Δρmin = −1.10 e Å−3 Absolute structure: Flack (1983 ▶), 489 Friedel pairs Flack parameter: 0.013 (17) Data collection: APEX2 (Bruker, 2004 ▶); cell refinement: SAINT (Bruker, 2004 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536809049757/rn2056sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809049757/rn2056Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
[Pt(C2H2O3)(NH3)2]Dx = 3.480 Mg m3
Mr = 303.19Mo Kα radiation, λ = 0.71073 Å
Orthorhombic, P212121Cell parameters from 1354 reflections
a = 5.6293 (6) Åθ = 2.9–28.3°
b = 7.2853 (8) ŵ = 24.17 mm1
c = 14.1107 (16) ÅT = 298 K
V = 578.70 (11) Å3Block, colourless
Z = 40.24 × 0.12 × 0.10 mm
F(000) = 544
Bruker APEXII CCD area-detector diffractometer1354 independent reflections
Radiation source: fine-focus sealed tube1307 reflections with I > 2σ(I)
graphiteRint = 0.034
phi and ω scansθmax = 28.3°, θmin = 2.9°
Absorption correction: multi-scan (SADABS; Sheldrick, 2002)h = −6→7
Tmin = 0.068, Tmax = 0.196k = −9→9
3739 measured reflectionsl = −17→18
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH-atom parameters constrained
R[F2 > 2σ(F2)] = 0.020w = 1/[σ2(Fo2) + (0.0103P)2] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.042(Δ/σ)max = 0.001
S = 0.99Δρmax = 1.24 e Å3
1354 reflectionsΔρmin = −1.10 e Å3
76 parametersExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
0 restraintsExtinction coefficient: 0.0087 (3)
Primary atom site location: structure-invariant direct methodsAbsolute structure: Flack (1983), 489 Friedel pairs
Secondary atom site location: difference Fourier mapFlack parameter: 0.013 (17)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Pt10.10734 (4)0.96205 (3)0.178777 (16)0.01860 (9)
N20.0429 (10)0.9713 (9)0.3193 (4)0.0310 (12)
H2A0.15741.03470.34790.047*
H2B0.03920.85770.34240.047*
H2C−0.09641.02560.32960.047*
N10.4267 (10)0.8432 (8)0.2082 (3)0.0272 (13)
H1A0.44710.74570.17110.041*
H1B0.42980.80850.26860.041*
H1C0.54270.92370.19760.041*
O10.1557 (8)0.9447 (7)0.0377 (3)0.0308 (11)
O2−0.2005 (8)1.0830 (7)0.1425 (3)0.0263 (11)
C1−0.0264 (12)0.9948 (9)−0.0099 (4)0.0230 (15)
C2−0.2372 (12)1.0639 (11)0.0439 (5)0.0332 (17)
H2E−0.28271.18230.01820.040*
H2D−0.36880.98030.03370.040*
O3−0.0334 (8)0.9898 (7)−0.0983 (3)0.0288 (11)
U11U22U33U12U13U23
Pt10.02166 (13)0.02149 (13)0.01266 (12)−0.00028 (10)−0.00029 (9)0.00010 (9)
N20.030 (3)0.043 (3)0.020 (3)0.003 (2)0.001 (2)−0.003 (3)
N10.033 (3)0.036 (3)0.012 (2)0.010 (3)0.005 (2)0.003 (2)
O10.028 (3)0.046 (3)0.018 (2)0.004 (2)0.0023 (19)−0.006 (2)
O20.027 (2)0.038 (3)0.014 (2)0.008 (2)−0.0030 (18)−0.0067 (19)
C10.027 (3)0.024 (4)0.018 (3)−0.003 (2)0.003 (2)0.003 (2)
C20.032 (4)0.052 (5)0.016 (3)0.011 (3)−0.002 (3)−0.004 (3)
O30.036 (3)0.038 (3)0.012 (2)−0.002 (2)−0.0002 (18)−0.0005 (19)
Pt1—O22.010 (5)N1—H1B0.8900
Pt1—O12.013 (4)N1—H1C0.8900
Pt1—N22.017 (5)O1—C11.279 (8)
Pt1—N12.038 (5)O2—C21.413 (7)
N2—H2A0.8900C1—O31.248 (8)
N2—H2B0.8900C1—C21.496 (9)
N2—H2C0.8900C2—H2E0.9700
N1—H1A0.8900C2—H2D0.9700
O2—Pt1—O183.82 (18)Pt1—N1—H1C109.5
O2—Pt1—N294.6 (2)H1A—N1—H1C109.5
O1—Pt1—N2176.9 (2)H1B—N1—H1C109.5
O2—Pt1—N1176.77 (19)C1—O1—Pt1113.2 (4)
O1—Pt1—N193.18 (18)C2—O2—Pt1109.5 (4)
N2—Pt1—N188.4 (2)O3—C1—O1122.8 (6)
Pt1—N2—H2A109.5O3—C1—C2119.5 (6)
Pt1—N2—H2B109.5O1—C1—C2117.7 (5)
H2A—N2—H2B109.5O2—C2—C1114.7 (6)
Pt1—N2—H2C109.5O2—C2—H2E108.6
H2A—N2—H2C109.5C1—C2—H2E108.6
H2B—N2—H2C109.5O2—C2—H2D108.6
Pt1—N1—H1A109.5C1—C2—H2D108.6
Pt1—N1—H1B109.5H2E—C2—H2D107.6
H1A—N1—H1B109.5
O2—Pt1—O1—C1−6.9 (4)Pt1—O1—C1—O3−178.2 (5)
N2—Pt1—O1—C153 (5)Pt1—O1—C1—C22.4 (8)
N1—Pt1—O1—C1174.3 (5)Pt1—O2—C2—C1−11.1 (7)
O1—Pt1—O2—C29.7 (4)O3—C1—C2—O2−173.3 (6)
N2—Pt1—O2—C2−167.7 (5)O1—C1—C2—O26.1 (10)
N1—Pt1—O2—C231 (4)
D—H···AD—HH···AD···AD—H···A
N1—H1C···O2i0.892.012.883 (8)167
N1—H1B···O2ii0.892.443.107 (7)132
N1—H1B···O3iii0.892.453.049 (7)125
N1—H1A···O3iv0.892.002.888 (7)173
N2—H2C···O3v0.892.323.108 (7)147
N2—H2B···O2ii0.892.213.014 (8)150
N2—H2A···O3iii0.892.263.010 (7)142
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N1—H1C⋯O2i 0.892.012.883 (8)167
N1—H1B⋯O2ii 0.892.443.107 (7)132
N1—H1B⋯O3iii 0.892.453.049 (7)125
N1—H1A⋯O3iv 0.892.002.888 (7)173
N2—H2C⋯O3v 0.892.323.108 (7)147
N2—H2B⋯O2ii 0.892.213.014 (8)150
N2—H2A⋯O3iii 0.892.263.010 (7)142

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) ; (v) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].

Authors:  T Taguchi; A Wakui; K Nabeya; M Kurihara; K Isono; T Kakegawa; K Ota
Journal:  Gan To Kagaku Ryoho       Date:  1992-04

3.  [A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].

Authors:  Y Inuyama; H Miyake; M Horiuchi; K Hayasaki; S Komiyama; K Ota
Journal:  Gan To Kagaku Ryoho       Date:  1992-06

4.  [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].

Authors:  K Noda; M Ikeda; M Yakushiji; H Nishimura; Y Terashima; H Sasaki; T Hata; H Kuramoto; K Tanaka; T Takahashi
Journal:  Gan To Kagaku Ryoho       Date:  1992-06

5.  Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices.

Authors:  Y Kameyama; N Okazaki; M Nakagawa; H Koshida; M Nakamura; M Gemba
Journal:  Toxicol Lett       Date:  1990-06       Impact factor: 4.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.